EWS
RXRX icon

Evergreen Wealth Solutions’s Recursion Pharmaceuticals RXRX Stock Holding History

Evergreen Wealth Solutions’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.1K Hold
10,000
– – ﹤0.01% 514
2026
Q1 		$30.7K Buy
+10,000
New +$38.6K ﹤0.01% 405

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Evergreen Wealth Solutions's RXRX Position: Q2 2026 in Review

Evergreen Wealth Solutions held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 10,000 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Evergreen Wealth Solutions first reported a position in RXRX in Q1 2026 and has held it in 2 quarters since. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Evergreen Wealth Solutions held 10,000 shares of Recursion Pharmaceuticals worth $33.1K as of Q2 2026.
  • Evergreen Wealth Solutions left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Evergreen Wealth Solutions's portfolio in Q2 2026, its #514 holding.
  • Evergreen Wealth Solutions first reported a position in Recursion Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Evergreen Wealth Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.